Differential effects of growth factor antagonists on neoplastic and normal prostatic cells
- 1 January 1990
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 17 (4) , 327-336
- https://doi.org/10.1002/pros.2990170408
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of transforming growth factor -α in human prostate cancer cell growthThe Prostate, 1989
- Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis.The Journal of cell biology, 1988
- Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinomaThe Prostate, 1988
- Comparative analysis of growth factors in normal and pathologic human prostatesThe Prostate, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast CarcinomaEndocrine Reviews, 1987
- Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.Proceedings of the National Academy of Sciences, 1986
- Role of epithelial‐stromal interactions in the control of gene expression in the prostate: An hypothesisThe Prostate, 1986
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- The Influence of Hormonal Therapy on Survival of Men with Advanced Prostatic CancerJournal of Urology, 1982